載入...

Safety and Immunogenicity of a Novel Intranasal Influenza Vaccine (NasoVAX): A Phase 2 Randomized, Controlled Trial

Annual influenza vaccination greatly reduces morbidity and mortality, but effectiveness remains sub-optimal. Weaknesses of current vaccines include low effectiveness against mismatched strains, lack of mucosal and other effective tissue-resident immune responses, weak cellular immune responses, and...

全面介紹

Na minha lista:
書目詳細資料
發表在:Vaccines (Basel)
Main Authors: Tasker, Sybil, Wight O’Rourke, Anna, Suyundikov, Anvar, Jackson Booth, Peta-Gay, Bart, Stephan, Krishnan, Vyjayanthi, Zhang, Jianfeng, Anderson, Katie J., Georges, Bertrand, Roberts, M. Scot
格式: Artigo
語言:Inglês
出版: MDPI 2021
主題:
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC8000446/
https://ncbi.nlm.nih.gov/pubmed/33807649
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/vaccines9030224
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!